BrainAurora Medical's Schizophrenia Study Results Published in International Journal
MT Newswires Live
Sep 02
BrainAurora Medical Technology (HKG:6681) has published the clinical research results titled "Randomized trial of self-adaptive computerized cognitive remediation in schizophrenia" in international academic journal npj Digital Medicine.
The clinical study was jointly conducted by the company, and Professor Wang Gang's team at Beijing Anding Hospital, Capital Medical University, according to a Wednesday Hong Kong bourse filing.
The study showed that self-adaptive cognitive training can boost and expedite cognitive improvement in patients with schizophrenia, particularly in the areas of attention and processing speed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.